INCY · Incyte Corporation
AI read · Neutral
The AI's read
The filing does not say why the insider sold. It reports no change to Incyte's medicines, sales, or plans. One person's trade alone gives no clear sign of a change in the business.
Incyte's filing reports an insider sold shares worth about $1.29 million. It gives no reason for the sale and reports no change to Incyte's business, so it does not change the company's outlook.
The filing does not say why the insider sold. It reports no change to Incyte's medicines, sales, or plans. One person's trade alone gives no clear sign of a change in the business.
Follow Incyte Corporation (INCY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for INCY